LDLR and familial hyperaldosteronism: Although the MLPA assay remains the reference method for the assessment of CNVs, Iacocca et al. demonstrated that NGS data from FH patients have a 100% concordance rate for large-scale LDLR CNVs calling using MLPA as the “gold standard” reference method [8].